Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. It operates through the following segments: Skincare, and Biomedical. The Skincare segment provides face masks, facial cleansers, and body care products. The Biomedical segment offers medical products such as bone graft substitute, ophthalmic viscoelastic, collagen dental graft, collagen wound dressing, and dermal filler injection. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.